Sernova Corp. appoints Jonathan Rigby as new CEO to lead innovative regenerative medicine efforts

London, Ontario and Boston, August 12, 2024 (Globe Newswire) -- Sernova Corp. has appointed Jonathan Rigby as its new CEO, enhancing its leadership as it advances regenerative medicine cell therapies. The company is currently leading a phase 1/2a clinical trial in type 1 diabetes. Rigby's experience is set to drive Sernova's mission forward.

Read full article here.